摘要
目的观察慢性持续期哮喘患儿心肌酶谱变化,探讨其临床意义。方法对于2010年1月~2012年12月在笔者医院哮喘专病门诊就诊的238例慢性持续期哮喘患儿进行心肌酶谱检测,给予吸入皮质激素和(或)白三烯调节剂,于治疗后3、6个月观察其临床症状评分(C—ACT)、肺功能(FEV1)、心肌酶谱的变化,并取同期儿童保健门诊体验的健康儿童40例为对照。结果236例哮喘患儿心肌酶谱CK—MB、CK、LDH、AST较健康儿童有显著性差异(P〈0.05)。治疗后3、6个月随着患儿的临床症状评分、肺功能的好转,心肌酶谱亦明显好转(P〈0,05)。结论慢性持续期哮喘患儿中由于炎症持续存在,心肌细胞也可能受到损伤,心肌酶谱发生改变。进行规范治疗后,随着临床症状评分和肺功能的改善,心肌酶谱也出现改善。
Objective To observe the changes of myocardial enzyme spectrum in pediatric asthma during chronic duration and ex- plore its clinical significance. Methods During Janaury 2010 to December 2012, the myocardial enzyme spectrum was tested in 236 ca- ses of children with chronic asthma duration in our hospital. The patients were given standard treatment of inhaled corticosteroids and/or leukotriene regulator. After 3 months and 6 months treatment, the changes of clinical symptom scores ( C - ACT) , pulmonary function (FEVI) , myocardial enzyme spectrum were observed. Meanwhile, we selected 40 health children as controls at the same period. Results Compared with healthy children,236 cases of asthma myocardial enzyme spectrum of CK - MB, CK, LDH, AST had significant differ- ence (P 〈 0. 05). After 3 months, 6 months treatment, the patients' clinical symptom scores, lung functions, myocardial enzyme spec- trum were improved obviously ( P 〈 0.05). Conclusion Due to persistent inflammation in pediatric asthma during chronic duration, car- diac cells may also be damaged, myocardial enzymes were changed. After standard treatment, with the improvement of clinical symptom scores, pulmonary functions, myocardial enzyme spectrums were also improved.
出处
《医学研究杂志》
2014年第1期126-128,共3页
Journal of Medical Research